{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:loop-diuretics",
  "owner": "cardio",
  "kind": "drug",
  "slug": "loop-diuretics",
  "name": "Loop diuretics",
  "aliases": [
    "Loop diuretic"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A group of diuretics, medicines that act on the kidney. A US label says one of them inhibits the absorption of sodium and chloride in the kidney tubules, including the loop of Henle. The US label read for one loop diuretic lists swelling from fluid build-up in congestive heart failure, cirrhosis and kidney disease, and says the oral form may also be used for high blood pressure.",
  "summary_technical": "Class page. MeSH descriptor D049994 (Sodium Potassium Chloride Symporter Inhibitors, last updated 2020-05-27) is recorded as a broad match: it is named for the mechanism, and its scope note describes agents that inhibit sodium-potassium-chloride symporters and act as diuretics. MeSH says excess use is associated with low blood potassium and high blood sugar. The label read is the US prescribing label of one brand-name furosemide tablet (application NDA016273, effective 2025-09-30 in openFDA); its openFDA record gives the established pharmacologic class Loop Diuretic. The label covers adults and pediatric patients for edema and adults for hypertension. This page gives no dose, no trial result and no guideline statement, and none of the label's warnings was recorded, including the warning on profound loss of water and electrolytes that opens its warnings section. Medicines of the group that have their own pages are filed under it.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-09",
  "last_evidence_check": "2026-11-09",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "mesh",
      "value": "D049994",
      "normalized_value": "D049994",
      "match": "broad",
      "version": "MeSH linked-data descriptor record fetched on 2026-11-09, lastUpdated 2020-05-27; the record states no yearly MeSH release",
      "label": "Sodium Potassium Chloride Symporter Inhibitors",
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "blood-vessels"
      ],
      "condition-area": [
        "heart-failure",
        "hypertension"
      ]
    }
  },
  "payload": {
    "level": "class",
    "mechanism": "A US label says the medicine it describes inhibits the absorption of sodium and chloride in the kidney tubules, including the loop of Henle. MeSH says agents in this group act as diuretics."
  },
  "content_digest": "721311ab54f38eb0ea5ad1d622a83fb7f70046fdacf10f6b745fc7aae599c164",
  "review": {
    "content_digest": "721311ab54f38eb0ea5ad1d622a83fb7f70046fdacf10f6b745fc7aae599c164",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-lasix-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:loop-diuretics",
      "category": "descriptive",
      "statement": "The US label of LASIX (furosemide tablets, Validus Pharmaceuticals LLC, application NDA016273; the version dated 2025-09-30 in openFDA) lists the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome, in adults and pediatric patients. It says oral LASIX may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. openFDA's record gives the established pharmacologic class Loop Diuretic. MeSH says agents of the matching descriptor act as diuretics.",
      "context": {
        "id": "cardio:ctx-fda-lasix-label-us",
        "label": "Adults and pediatric patients with edema, and adults with hypertension, as described in the US label of a loop diuretic",
        "recipient": "mixed",
        "population": "Patients described in the indications section of the label: adults and pediatric patients with edema associated with congestive heart failure, cirrhosis of the liver or renal disease, and adults with hypertension.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (US drug label)",
        "life_stage_note": "Adults and pediatric patients for edema; adults for hypertension, as the label states",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Adults and pediatric patients with edema associated with congestive heart failure, cirrhosis of the liver or renal disease",
            "Adults with hypertension"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what one US label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The pharmacologic class name comes from openFDA's record of the label. Other loop diuretic labels list different uses. Contraindications, warnings, interactions and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], INDICATIONS AND USAGE",
          "applicability_note": "Edema and hypertension uses.",
          "snapshot": {
            "id": "cardio:openfda-label-lasix-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:37Z",
            "content_hash": "ed9855aad2ab51bda46903f2319af7d32d4fcf9954b059cd6afc33672d16a4f0",
            "source_effective_date": "2025-09-30",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-lasix",
            "source_type": "regulator",
            "title": "openFDA drug label record for LASIX (furosemide tablets), Validus Pharmaceuticals LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%222c9b4d8f-0770-482d-a9e6-9c616a440b1a%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 2c9b4d8f-0770-482d-a9e6-9c616a440b1a (manufacturer Validus Pharmaceuticals LLC, application NDA016273), returned on 2026-11-09. The label text is dated 2025-09-30 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-lasix.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].openfda.pharm_class_epc[0]",
          "applicability_note": "Established pharmacologic class in openFDA: Loop Diuretic.",
          "snapshot": {
            "id": "cardio:openfda-label-lasix-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:37Z",
            "content_hash": "ed9855aad2ab51bda46903f2319af7d32d4fcf9954b059cd6afc33672d16a4f0",
            "source_effective_date": "2025-09-30",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-lasix",
            "source_type": "regulator",
            "title": "openFDA drug label record for LASIX (furosemide tablets), Validus Pharmaceuticals LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%222c9b4d8f-0770-482d-a9e6-9c616a440b1a%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 2c9b4d8f-0770-482d-a9e6-9c616a440b1a (manufacturer Validus Pharmaceuticals LLC, application NDA016273), returned on 2026-11-09. The label text is dated 2025-09-30 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-lasix.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20250930.",
          "snapshot": {
            "id": "cardio:openfda-label-lasix-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:37Z",
            "content_hash": "ed9855aad2ab51bda46903f2319af7d32d4fcf9954b059cd6afc33672d16a4f0",
            "source_effective_date": "2025-09-30",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-lasix",
            "source_type": "regulator",
            "title": "openFDA drug label record for LASIX (furosemide tablets), Validus Pharmaceuticals LLC label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%222c9b4d8f-0770-482d-a9e6-9c616a440b1a%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 2c9b4d8f-0770-482d-a9e6-9c616a440b1a (manufacturer Validus Pharmaceuticals LLC, application NDA016273), returned on 2026-11-09. The label text is dated 2025-09-30 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-lasix.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "scopeNote.@value",
          "applicability_note": "MeSH scope note: the agents act as diuretics.",
          "snapshot": {
            "id": "cardio:mesh-scope-d049994-2026-11-09",
            "retrieved_at": "2026-11-09T13:15:46Z",
            "content_hash": "5b779b15d6a5e90ccf188a1787b22597dfb8060a2483888d21493018350e5ec7",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:mesh-scope-d049994",
            "source_type": "dataset",
            "title": "MeSH scope note for descriptor D049994 (Sodium Potassium Chloride Symporter Inhibitors)",
            "canonical_url": "https://id.nlm.nih.gov/mesh/M0471884",
            "identifiers": [
              {
                "scheme": "mesh",
                "value": "M0471884",
                "normalized_value": "M0471884",
                "match": "exact",
                "version": "id.nlm.nih.gov linked data, preferred concept of descriptor D049994, retrieved 2026-11-09",
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. National Library of Medicine",
            "edition": "MeSH linked-data record of the preferred concept M0471884 of descriptor D049994, fetched 2026-11-09. The scope note is on this concept record, not on the descriptor record.",
            "reuse_basis": "The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed at research/snapshots/w4k03-meshc-M0471884.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "be7d2dc0c8d23b416abbd05d41731771dced8f6c5b32bb32a282f24c6c3ecb22",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-lasix-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "evaluated_for",
        "label": "A US label lists fluid build-up from congestive heart failure as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:heart-failure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-lasix-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "A US label says the oral form may be used for high blood pressure",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-lasix-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Blood pressure lowering medicine, the care strategy",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:bp-lowering-medicine",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:bumetanide",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-1808-2026-11-18",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:furosemide",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-4603-2026-11-18",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:torsemide",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-38413-2026-11-18",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/loop-diuretics/",
  "context_path": "api/v1/context/cardio--loop-diuretics.md"
}
